π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
The study will be a single-center, randomized Phase II study of conventiona...
Status
Withdrawn
Location
Smilow Cancer Center
Start Date
2016-06
Trial ID
NCT02908165
This study is a prospective non-randomized controlled study. The purpose of...
Status
Unknown
Location
Cancer Hospital and Institute, Chinese Academy of Medical Sciences
Start Date
2015-08
Trial ID
NCT02537158
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04479527
Treatments Being Tested
The purpose of this study is to determine whether neoadiuvant therapy with ...
Status
Completed
Location
UOSC Epatologia - Cardarelli Hospital
Start Date
2012-01
Trial ID
NCT01507064
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common malignancy, and its incidence is...
Status
Unknown
Location
Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University
Start Date
2019-02-01
Trial ID
NCT02436902
Treatments Being Tested
Sorafenib is the standard therapy for hepatocellular carcinoma (HCC) with e...
Status
Unknown
Location
Korea University Ansan Hospital
Start Date
2012-03-01
Trial ID
NCT03518502
Treatments Being Tested
This study uses to suppress the growth of tumors, extend the patient's surv...
Status
Unknown
Location
Multiple Locations
Start Date
2018-05-01
Trial ID
NCT03511703
Treatments Being Tested
This clinical trial is aimed at extending the chance of liver transplantati...
Status
Completed
Location
Ospedali Riuniti di Bergamo
Start Date
2011-01
Trial ID
NCT01387503
Treatments Being Tested
Transarterial chemoembolization (TACE) based on drug-eluting beads (DEB-TAC...
Status
Unknown
Location
Guangxi Medical University Cancer Hospital
Start Date
2021-02-02
Trial ID
NCT04229355
Treatments Being Tested